| Literature DB >> 30818384 |
Tsutomu Yasukawa1, Ryusaburo Mori2, Miki Sawa3, Ari Shinojima2, Chikako Hara3, Tetsuju Sekiryu4, Yuji Oshima5, Masaaki Saito4,6, Yukinori Sugano4, Aki Kato1, Masayuki Ashikari1, Yoshio Hirano1, Hitomi Asato5, Mayumi Nakamura7, Kiyoshi Matsuno7, Noriyuki Kuno7,8, Erika Kimura7, Takeshi Nishiyama9, Mitsuko Yuzawa2, Tatsuro Ishibashi5, Yuichiro Ogura1, Tomohiro Iida4,10, Fumi Gomi3,11.
Abstract
PURPOSE: Abnormal fundus autofluorescence (FAF) potentially precedes onset of late age-related macular degeneration (AMD) in Caucasian patients. Many differences exist between Asian and Caucasian patients regarding AMD types and severity, gender, and genetic backgrounds. We investigated the characteristics of abnormal FAF and retinal sensitivity in the fellow eyes of Japanese patients with unilateral neovascular AMD.Entities:
Mesh:
Year: 2019 PMID: 30818384 PMCID: PMC6394952 DOI: 10.1371/journal.pone.0213161
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart for classifying abnormal FAF.
Baseline profiles of 66 study patients.
| Age (mean ± SD, years) | 73.7±7.5 |
| Gender | |
| Male | 48 (72.7%) |
| Female | 18 (27.3%) |
| Diagnosis of study eye—no. (%) | |
| Medium-to-large drusen and/or pigmentary abnormalities | 65 (98.5%) |
| Extrafoveal GA | 1 (1.5%) |
| Diagnosis of fellow eye—no. (%) | |
| Typical neovascular AMD | 46 (69.7%) |
| PCV | 19 (28.8%) |
| RAP | 1 (1.5%) |
SD, standard deviation.
Fig 2Changes in the mean BCVA logMAR and mean retinal sensitivity during the follow-up period.
The data are expressed as the mean ± standard error of the mean. *P<0.01 compared with baseline (paired t-test).
Proportion and retinal sensitivity of abnormal FAF patterns.
SD, standard deviation.
| Patterns of abnormal FAF | n (%) | Retinal sensitivity (dB) | % of points with 11 dB or better |
|---|---|---|---|
| Minimal change | 3 (4.5) | 14.5 +/- 2.3 | 97 |
| Focally increased | 20 (30.3) | 14.6 +/- 4.1 | 84 |
| Linear | 5 (7.6) | 14.6 +/- 3.7 | 87 |
| Focal plaque-like | 4 (6.1) | 14.4 +/- 3.4 | 83 |
| Reticular | 4 (6.1) | 13.2 +/- 4.5 | 72 |
| Patchy | 22 (33.3) | 13.1 +/- 4.8 | 72 |
| Lace-like | 6 (9.1) | 11.8 +/- 4.0 | 63 |
| Speckled | 2 (3.0) | 9.8 +/- 3.2 | 40 |
| Total | 66 (100) | 13.5 +/- 4.5 | 77 |
Fig 3The relationship between retinal sensitivity and the distance from the abnormal FAF.
(A) The temporal changes in the mean retinal sensitivity in three groups. (†P<0.01 vs. close at each time point, ANOVA). (B) The changes in the mean retinal sensitivity from baseline in the three groups. The data are expressed as the mean ± standard error of the mean. (*P<0.05 and **P<0.01 as compared with baseline, paired t-test).
Results of the random intercept and slope model.
| Parameter | Estimate | SE | ||
|---|---|---|---|---|
| Distance | Within | Reference | ||
| Close | 1.18 | 0.36 | 0.001 | |
| Distant | 2.65 | 0.33 | <0.001 | |
| Time | 0.05 | 0.02 | 0.031 | |
| Test point location (degrees) | 0.29 | 0.04 | <0.001 | |
SE, standard error of the mean.
Fig 4The proportion of points with a 4-dB or greater decline in the groups in which the distances to the abnormal FAF differed (P = 0.113, Fisher’s exact test).
Characteristics of six eyes with progression to neovascular AMD.
| Case | Age | Month with withdrawal | Mean retinal sensitivity | Abnormal | Hard | Soft | Confluent | Hyper-Pigmentation | Hypo-Pigmentation/atrophy | |
|---|---|---|---|---|---|---|---|---|---|---|
| baseline | 6 M | |||||||||
| 1 | 77 | 12 | 11.0 | 16.6 | Linear | - | + | - | - | - |
| 2 | 70 | 6 | 13.3 | - | Patchy | + | + | + | + | - |
| 3 | 75 | 3 | 19.7 | - | Focal increase | NA | ||||
| 4 | 83 | 12 | 11.5 | 8.8 | Focal increase | - | + | - | + | + |
| 5 | 81 | 12 | 8.0 | 9.8 | Patchy | - | + | - | + | - |
| 6 | 60 | 9 | 12.4 | 14.6 | Lace-like | + | + | - | + | - |
M, months; NA, not analyzed.
Fig 5The impact of supplementation on the mean retinal sensitivity.
(A) The temporal changes in the mean retinal sensitivity in groups with and without supplementation. (B) The changes in the mean retinal sensitivity from baseline. (†P<0.01, ANOVA; *P<0.01 compared with baseline, paired t-test).
Characteristics of patients with or without supplementation.
| Antioxidant supplementation | P value | |||
|---|---|---|---|---|
| + | - | |||
| Age | 70.2±6.8 | 75.6±6.9 | 0.0216 | |
| Sex | Men | 13 | 12 | 1.0000 |
| Women | 7 | 6 | ||
| Smoking | Current | 1 | 5 | 0.0304 |
| Ever | 8 | 8 | ||
| Never | 11 | 3 | ||
| Unknown | 0 | 2 | ||